Search
NVP-LEQ-506
go.drugbank.com/drugs/DB12857InvestigationalLEQ506 has been used in trials studying the treatment of Advanced Solid Tumors, Recurrent or Refractory Medulloblastoma, and Locally Advanced or Metastatic Basal Cell Carcinoma.
PRTX-100
go.drugbank.com/drugs/DB05947InvestigationalPRTX-100 is a highly-purified form of Staphylococcal Protein A that binds directly to monocytes and a subset of B-cells that are involved in the development and progression of various autoimmune diseases
Hydrogenated soybean oil
go.drugbank.com/drugs/DB11302ApprovedIt may be found in cosmetics and personal care products as an emollient or skin conditioning agent. … According to the FDA, hydrogenated soybean oil is generally recognized as safe (GRAS) food substance.
Phenaridine
go.drugbank.com/drugs/DB09178ExperimentalIllicitIt was developed in 1972, and is used for surgical anasthesia in Russia. Phenaridine has similar effects to fentanyl. In rat studies, it was less potent than fentanyl.
Curcuma aromatica root oil
go.drugbank.com/drugs/DB11301ApprovedCurcuma aromatica root oil is obtained from the roots of *Curcuma aromatica*, or more commonly called wild tumeric, via steamed distillation. *Curcuma aromatica* belongs to the family Zingiberaceae.
V590
go.drugbank.com/drugs/DB16437ExperimentalMerck is currently underway to begin Phase I trials for the vaccine through intramuscular administration (NCT04569786).
KBP-COVID-19
go.drugbank.com/drugs/DB15858InvestigationalKBP cloned COVID-19’s genetic sequence, identified a potential antigen, and then inserted it into tobacco plants for reproduction.
Bleomycin A6
go.drugbank.com/drugs/DB12992InvestigationalThis drug participated in clinical trials for the treatment of Squamous Cell Lung Cancer.
Brofaromine
go.drugbank.com/drugs/DB13876ExperimentalCategories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesLitifilimab
go.drugbank.com/drugs/DB18864InvestigationalChronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory And/or Intolerant to Antimalarial Therapy). … is under investigation in clinical trial NCT05531565 (A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) And/or